Department of General Surgery, Hacettepe University Medical School, 06100, Sihhiye, Ankara, Turkey.
Tech Coloproctol. 2010 Mar;14(1):9-12. doi: 10.1007/s10151-009-0546-7. Epub 2009 Dec 2.
The aim of this study was to perform an external validation of Cleveland Clinic Foundation colorectal cancer model in a single center.
Relevant data of 771 patients who underwent surgery for colorectal cancer between January 1997 and November 2008 were retrospectively collected. The performance of the scoring system was evaluated by discrimination and calibration. Discrimination was evaluated by using the area under the receiver operator characteristics curve and calibration by using the Hosmer-Lemeshow goodness-of-fit test.
Mean age was 60.8 (18-91). Forty-four percent of patients were female, and 56% were male. Overall mortality was 3.9%. Cleveland Clinic Foundation colorectal cancer model showed good discrimination but poor calibration.
These data suggest that the Cleveland Clinic Foundation colorectal cancer model is a suitable model to be used in our center for patients with colorectal cancer but requires recalibration.
本研究旨在对克利夫兰诊所基金会结直肠癌模型进行单中心外部验证。
回顾性收集 1997 年 1 月至 2008 年 11 月期间接受结直肠癌手术的 771 例患者的相关数据。通过区分度和校准度评估评分系统的性能。区分度采用接受者操作特征曲线下面积评估,校准度采用 Hosmer-Lemeshow 拟合优度检验评估。
平均年龄为 60.8 岁(18-91 岁)。44%的患者为女性,56%的患者为男性。总死亡率为 3.9%。克利夫兰诊所基金会结直肠癌模型具有良好的区分度,但校准度较差。
这些数据表明,克利夫兰诊所基金会结直肠癌模型是适用于本中心结直肠癌患者的模型,但需要重新校准。